TSS
ABBV icon

Two Sigma Securities’s AbbVie ABBV Stock Holding History

Two Sigma Securities’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-58,500
Closed -$11.6M – 1560
2024
Q3 		$11.6M Sell
58,500
-98,400
-63% -$18.4M 0.2% 125
2024
Q2 		$26.9M Sell
156,900
-96,900
-38% -$16.1M 0.33% 50
2024
Q1 		$46.2M Buy
253,800
+177,400
+232% +$30.6M 0.45% 32
2023
Q4 		$11.8M Sell
76,400
-169,600
-69% -$24.7M 0.11% 188
2023
Q3 		$36.7M Buy
246,000
+162,200
+194% +$23.8M 0.39% 37
2023
Q2 		$11.3M Sell
83,800
-137,800
-62% -$20.2M 0.17% 129
2023
Q1 		$35.3M Buy
221,600
+68,700
+45% +$10.5M 0.71% 11
2022
Q4 		$24.7M Buy
152,900
+1,700
+1% +$261K 0.74% 9
2022
Q3 		$20.3M Buy
151,200
+14,400
+11% +$2.07M 0.61% 12
2022
Q2 		$21M Buy
136,800
+90,000
+192% +$13.8M 0.74% 13
2022
Q1 		$7.59M Buy
46,800
+44,800
+2,240% +$6.51M 0.27% 62
2021
Q4 		$271K Sell
2,000
-38,100
-95% -$4.5M 0.01% 876
2021
Q3 		$4.33M Buy
40,100
+5,100
+15% +$583K 0.13% 135
2021
Q2 		$3.94M Buy
+35,000
New +$3.94M 0.12% 119
2021
Q1 		– Sell
-41,600
Closed -$4.46M – 797
2020
Q4 		$4.46M Buy
41,600
+27,500
+195% +$2.64M 0.11% 119
2020
Q3 		$1.24M Sell
14,100
-4,100
-23% -$386K 0.03% 301
2020
Q2 		$1.79M Sell
18,200
-9,800
-35% -$863K 0.04% 253
2020
Q1 		$2.13M Sell
28,000
-191,500
-87% -$16.3M 0.05% 238
2019
Q4 		$19.4M Buy
219,500
+24,800
+13% +$2.06M 0.13% 103
2019
Q3 		$14.7M Buy
194,700
+200
+0.1% +$13.7K 0.13% 107
2019
Q2 		$14.1M Buy
194,500
+180,400
+1,279% +$14.2M 0.15% 91
2019
Q1 		$1.14M Sell
14,100
-64,800
-82% -$5.3M 0.01% 508
2018
Q4 		$7.27M Sell
78,900
-72,700
-48% -$6.39M 0.09% 118
2018
Q3 		$14.3M Sell
151,600
-82,000
-35% -$7.78M 0.09% 143
2018
Q2 		$21.6M Sell
233,600
-158,000
-40% -$15.4M 0.11% 144
2018
Q1 		$37.1M Buy
391,600
+387,300
+9,007% +$42.5M 0.21% 77
2017
Q4 		$416K Buy
+4,300
New +$405K 0.01% 799

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Securities's ABBV Position: Q3 2025 in Review

Two Sigma Securities sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 15,656 shares — an estimated $2.91M sold.

Two Sigma Securities first reported a position in ABBV in Q3 2015 and held it in 21 quarters. The position peaked at $5.49M in Q1 2018. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Two Sigma Securities reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 15,656 AbbVie shares in Q3 2025, an estimated $2.91M.
  • Two Sigma Securities first reported a position in AbbVie in Q3 2015 and held it in 21 quarters.
  • Two Sigma Securities's AbbVie position peaked at $5.49M in Q1 2018.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.